Skip to the page

Data / Drug companies / Human immunoglobulin g

Human immunoglobulin g: 5 companies and 15 products in the FDA NDC directory

Human immunoglobulin g is listed in the FDA National Drug Code Directory by 5 companies, with 15 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are liquid; solution; injection, solution, and the newest product started marketing on September 26, 2025.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
5
Products
15
Generic (ANDA) products
0 (0.0%)
Application numbers
6
Routes
Intravenous, Subcutaneous
Brand names
Hizentra, Privigen, Gammaplex, Qivigy Kthm, Alyglo, Asceniv
openFDA record search
api.fda.gov

Companies that list human immunoglobulin g

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
CSL Behring AG11liquidBiologics (BLA)January 1, 2020
Adma Biologics, Inc.1liquidBiologics (BLA)April 1, 2019
Bio Products Laboratory Ltd1solutionBiologics (BLA)April 7, 2017
GC Biopharma Corp.1liquidBiologics (BLA)December 15, 2023
Kedrion S.p.A1injection, solutionBiologics (BLA)September 26, 2025

Dosage forms

Dosage formProductsShare
Liquid1386.7%
Solution16.7%
Injection, solution16.7%

Marketing categories

Marketing categoryProductsShare
Biologics (BLA)15100%

Pharmacologic classes

ClassProducts
Human Immunoglobulin G15

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.